Estimating Mycophenolic Acid Levels in Liver Transplant Patients
Author Information
Author(s): Marcos Bernardino Bouzas, Lorena Tutor, J. Carlos Tutor
Primary Institution: Hospital Clínico Universitario, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain
Hypothesis
Can a limited sampling strategy accurately estimate the area under the curve of mycophenolic acid in liver transplant recipients?
Conclusion
The trapezoidal extrapolated AUC(0–8h) may be useful for routine therapeutic monitoring of mycophenolic acid in liver transplant recipients.
Supporting Evidence
- A tentative therapeutic range for MPA AUC(0–8h) of about 20–40 μg.h/mL is proposed.
- In patients with supratherapeutic values, the total leukocyte blood count was significantly lower.
- Significant negative correlations were found between total leukocyte count and MPA levels.
Takeaway
This study helps doctors figure out how much of a medicine called mycophenolic acid liver transplant patients need by taking fewer blood samples.
Methodology
The study involved monitoring MPA levels in 22 liver transplant patients and calculating the trapezoidal extrapolated AUC(0–8h) using blood samples taken at specific times.
Limitations
The study was limited to a small sample size and may not be generalizable to all liver transplant patients.
Participant Demographics
17 males and 5 females with a mean age of 58.1 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website